PERCEPTIVE ADVISORS LLC

Position in APGE — Apogee Therapeutics, Inc.

CIK 1224962 NEW YORK, NY

Position in APGE

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$173,625,838

+$43,971,717 QoQ

Shares Held

1,308,113

-15.1% QoQ

Ownership

1.73%

of shares outstanding

% of Portfolio

2.80%

of 13F equity value

Holder Rank

#17

of 285 holders

Holding Since

Sep 2023

12 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

PERCEPTIVE ADVISORS LLC holds $5,486,611,234 across 68 Biotechnology names. APGE ranks #11 (3.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	PRAX	Praxis Precision Medicines, Inc.	2,035,986	$681,627,752
2	SYRE	Spyre Therapeutics, Inc.	4,319,496	$383,484,854
3	CELC	Celcuity Inc.	3,197,200	$334,491,064
4	ASND	Ascendis Pharma A/S	1,163,721	$310,387,665
5	RYTM	Rhythm Pharmaceuticals, Inc.	2,586,295	$287,156,333
6	ROIV	Roivant Sciences Ltd.	8,085,461	$286,144,464
7	RLAY	Relay Therapeutics, Inc.	14,106,187	$263,926,758
8	TVTX	Travere Therapeutics, Inc.	3,752,574	$213,183,728

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$173,625,838	1,308,113	-15.1%	Shares	Sole	2026-08-14
2026-03-31	$129,654,121	1,540,384	-33.9%	Shares	Sole	2026-05-29
2025-12-31	$175,917,537	2,330,651	+72.4%	Shares	Sole	2026-02-17
2025-09-30	$53,714,522	1,351,989	+14.4%	Shares	Sole	2025-11-14
2025-06-30	$51,340,687	1,182,148	+5.3%	Shares	Sole	2025-08-14
2025-03-31	$41,946,575	1,122,767	+7.2%	Shares	Sole	2025-08-06
2024-12-31	$47,439,609	1,047,232	-48.0%	Shares	Sole	2025-02-14
2024-09-30	$118,361,511	2,015,007	-4.3%	Shares	Sole	2024-11-14
2024-06-30	$82,856,776	2,105,636	+2.2%	Shares	Sole	2024-08-16
2024-03-31	$136,913,247	2,060,395	+12.7%	Shares	Sole	2024-08-06
2023-12-31	$51,071,553	1,827,901	0.0%	Shares	Sole	2024-02-26
2023-09-30	$38,934,291	1,827,901	—	Shares	Sole	2023-11-14
No filing history on record for this holder in this stock.